Elacridar hydrochlorideProduct ingredient for Elacridar
- Name
- Elacridar hydrochloride
- Drug Entry
- Elacridar
Elacridar (GW120918) is an oral bioenhancer that targets multiple drug resistance in tumors. In many cases, the appearance of multidrug resistance in cancer is due to a change in expression of protein inhibitors. As of August 2007 elacridar was not listed on GSK's product pipeline. Development is assumed to have been discontinued.
- Accession Number
- DBSALT000816
- Structure
Structure for Elacridar hydrochloride (DBSALT000816)
- Synonyms
- Elacridar HCl